FTSE 100 and FTSE 250 investors! Should you buy healthcare shares in 2020?

Many healthcare stocks listed in the FTSE 100 (INDEXFTSE: UKX) and the FTSE 250 (INDEXFTSE:UKX) may help investors diversify their portfolios.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Are we really almost at the tail end of nearly a decade of economic growth? Yes we are. Although there have been a few short-lived downturns over the past 10 years, most economies have enjoyed stable growth since the recession of 2008-09.

But I have been increasingly noticing the economically dreaded R-word in the media. While analysts are divided as to whether many global economies, including the UK, could be headed towards a recession in the near future, investors could benefit from thinking about how to recession-proof their portfolios. 

Here are several healthcare shares that may be appropriate for many long-term portfolios in 2020.

A resilient industry

By healthcare, I mean pharmaceutical companies, as well as medical device manufacturers and those that operate healthcare facilities.

Healthcare companies are considered to be defensive and their shares might serve investors well in case of a recession. A defensive company usually has a constant demand for its products or services and isn’t typically correlated to the rest of the business cycle. 

Why is healthcare so resilient? We all get sick occasionally, or have friends and relatives who may need treatment for chronic illness. Moreover, according to the Office for National Statistics, the UK population is getting older with “18% aged 65 and over and 2.4% aged 85 and over.” Hence the need for more healthcare facilities and drugs.  

The sector also benefits from technological advances as innovation, ranging from medical equipment technology to information technology, increasingly plays a crucial role in sustaining health.

FTSE 100 shares

Britain’s leading stock index, the FTSE 100, offers several possibilities for investors to consider. Two stocks that may be worthy of your attention would be the FTSE 100 pharma giants AstraZeneca and GlaxoSmithKline.

When major indices or economies come under stress, more than ever I look for companies that offer fundamental value and growth potential, as well as proven stability. Overall, both shares fit the criteria well. With respective dividend yields of 2.9% and 4.5%, they are likely to appeal to income investors too.

Generic drug specialist Hikma Pharmaceuticals, Abu Dhabi-based healthcare centre operator NMC Health and medical technology company Smith & Nephew are the three other stocks I’d consider in the New Year.

Most FTSE 100 companies generate a large proportion of their revenues from outside the UK, especially the US and emerging markets, meaning that they should be well insulated from any potential Brexit-related economic downturn after the general election.

FTSE 250 and AIM stocks

Outside the FTSE 100, investors would be able to find several companies that are listed in the FTSE 250 and AIM, the London Stock Exchange’s market for smaller companies.

One such share is Mediclinic International, a private healthcare group with global operations. It also holds a 30% interest in UK specialist Spire Healthcare Group. 

Another company would be UDG Healthcare, which provides non-core but essential services such as packaging, marketing and communications for global drug makers.

My next stock is AIM-listed Abcam that sells research-grade antibodies, biological reagents and tools to pharma and biotech laboratories that conduct scientific experiments. 

Finally, if you want to look beyond our borders, then you may want to do due diligence on the Worldwide Healthcare Trust. It is invested around the world in healthcare stocks. Year-to-date it is up over 25% and has a dividend yield of 0.89%. Its annual expense ratio stands at 0.9%.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

tezcang owns GlaxoSmithKline covered calls (December 13 expiry) on GSK ADR shares listed on NYSE. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline and NMC Health. The Motley Fool UK has recommended Abcam, AstraZeneca, Hikma Pharmaceuticals, and UDG Healthcare. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »